Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the launch of OsteGro, an allograft bone matrix that supports new bone growth in orthopedic surgical procedures. The launch of OsteGro further expands the company’s bone repair franchise. “We are excited
Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Biotechnology startup Molecular Matrix Inc. has received 510(k) FDA clearance for a carbohydrate-based polymer that can help injured bones heal and regrow, reports the University of California, Davis, on its website. Osteo-P is a synthetic bone graft substitute that supports and
Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, recently announced that its HA-based bone void filler received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is indicated for filling bone voids or defects of the skeletal system (i.e. extremities and pelvis), which are not intrinsic to the stability of the bone, created during surgery or resulting from traumatic injury.
These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially demineralized allograft particles.
Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology.
Firm wants data on best dosage of controversial bone-growth product.
The U.S. orthopedic biomaterials market is expected to increase to exceed $4.5 billion by 2023
By Payam Moghimi-Bidhendi and Jesse Spicer – iData Research Inc. The European orthopedic biomaterials market is broadly driven by the aging population and for being an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware. Orthopedic surgeries are generally complicated, multi-stage procedures that result in longer recovery times and increased
